PARIS—Patients with severely bothersome overactive bladder (OAB) symptoms who have failed treatment with tolterodine ER may benefit by switching to solifenacin, research suggests. At the Société ...
Do not use if you have ever had an allergic reaction to SOLIFENACIN VIATRIS or any of the ingredients listed at the end of the CMI. There are a number of circumstances in which a person should not use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results